Smart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical Translation
Small · 2025-02 · 21 (7)
DOI: 10.1002/smll.202408898 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 22.01.2025. Verfasst von Satar Yousefiasl und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, 1417614411, Iran. Hauptthemen laut MEDLINE: Silicon Dioxide, Nanoparticles, Neoplasms, Translational Research, Biomedical. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 293 Literaturangaben.
Abstract (Originalsprache)
In cancer research and personalized medicine, mesoporous silica nanoparticles (MSNs) have emerged as a significant breakthrough in both cancer treatment and diagnosis. MSNs offer targeted drug delivery, enhancing therapeutic effectiveness while minimizing adverse effects on healthy cells. Due to their unique characteristics, MSNs provide targeted drug delivery, maximizing therapeutic effectiveness with minimal adverse effects on healthy cells. The review thoroughly investigates the role of MSNs as potent drug carriers, noted for their high drug‐loading capacity and controlled release, which significantly improves drug permeability and retention. Additionally, it discusses surface modification techniques that enable MSNs to target cancer cells precisely. The manuscript provides comprehensive insights into various MSN applications, including their role in cancer diagnosis, the design of advanced biosensors, and the development of both conventional and stimuli‐responsive drug delivery platforms. Special focus is given to stimuli‐triggered MSN systems, responsive to internal stimuli (e.g., pH, redox, enzyme) and external stimuli (e.g., temperature, magnetic field, light, ultrasound), highlighting the cutting‐edge progress in MSN technology. Additionally, the review delves into the immunogenicity and biosafety aspects of MSNs, underscoring their potential for clinical translation. Besides summarizing the current state of MSN research in oncology, this review also illuminates the path for future advancements and clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, 1417614411, Iran.
- Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, CA, 90095, USA.
- Cancer Research Center, Institute of Cancer, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan, 6517838636, Iran.
- Department of Tissue Engineering and Biomaterials, School of Advanced Medical Sciences and Technologies, Hamadan University of Medical Sciences, Hamadan, 6517838736, Iran.
- Poursina Hakim Digestive Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, 8198314271, Iran.
- Department of Pharmacy, School of Health Sciences, Central University of South Bihar, Gaya, 824209, India.
ORCID-Profile: Satar Yousefiasl, Mahsa Ghovvati, Pooyan Makvandi
Zitieren
APA
Yousefiasl, S., Ghovvati, M., Alibakhshi, A., Azizi, M., Samadi, P., Kumar, A., Shojaeian, A., Sharifi, E., Zare, E. N., Dey, A. D., Chehelgerdi, M., & Makvandi, P. (2025). Smart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical Translation. Small, 21(7). https://doi.org/10.1002/smll.202408898
Vancouver
Yousefiasl S, Ghovvati M, Alibakhshi A, Azizi M, Samadi P, Kumar A, et al. Smart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical Translation. Small. 2025;21(7). doi:10.1002/smll.202408898
BibTeX
@article{Yousefiasl2025,
author = {Yousefiasl, Satar and Ghovvati, Mahsa and Alibakhshi, Abbas and Azizi, Mehdi and Samadi, Pouria and Kumar, Arun and Shojaeian, Ali and Sharifi, Esmaeel and Zare, Ehsan Nazarzadeh and Dey, Asmita Deka and Chehelgerdi, Mohammad and Makvandi, Pooyan},
title = {Smart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical Translation},
journal = {Small},
year = {2025},
volume = {21},
number = {7},
doi = {10.1002/smll.202408898}
}
EUVIMED